Efemoral Medical Reports Exceptional Long-Term EFEMORAL I Results Highlighting Durability and Differentiated Performance in Femoropopliteal Disease

Novel bioresorbable scaffold demonstrates primary patency rate of 97% at 3 years, indicative of long-term efficacy Achieved 1% post-procedural residual stenosis rate -- lowest rate ever reported in a clinical trial of femoropopliteal intervention LOS ALTOS, Calif., April 21, 2026...